Endoscopic surgery for noninvasive prolactinomas: A large multicenter, single-arm, retrospective study (PRLomaSaR)
Authors:
- 21 January 2026
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 91 (1) , 44
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82201616)
- National Natural Science Foundation of China (82000749)
- National Natural Science Foundation of China (82141114, 81972339)
- Clinical Research Fund from Shanghai Municipal Health Commission (20224Y0027)
- Science and Technology Commission of Shanghai Municipality (22Y11904700)
This publication has 32 references indexed in Scilit:
- Surgery for Prolactinomas to DateNeuroendocrinology, 2019
- Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysisEndocrine, 2017
- THERAPY OF ENDOCRINE DISEASE: Surgery in microprolactinomas: effectiveness and risks based on contemporary literatureEuropean Journal of Endocrinology, 2016
- Clinical Impact of the Current WHO Classification of Pituitary AdenomasEndocrine Pathology, 2016
- Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patientsEuropean Journal of Endocrinology, 2012
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinusJournal of Neurosurgery, 2010
- Advances in the Treatment of ProlactinomasEndocrine Reviews, 2006
- Dopamine receptor agonists for treating prolactinomasExpert Opinion on Investigational Drugs, 2002
- Pituitary Adenomas with Invasion of the Cavernous Sinus SpaceNeurosurgery, 1993